Get a free sample of Neurothrombectomy Devices Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Neurothrombectomy Devices Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Neurothrombectomy Devices Market Size
Neurothrombectomy Devices Market was valued at USD 659 million in 2023 and is anticipated to attain 7.3% CAGR from 2024 to 2032. Neurothrombectomy devices belong to the category of neurovascular devices, which is estimated to reach 7.5 billion by 2032, designed to mechanically remove blood clots from vessels within the central nervous system, serving a crucial role in the acute ischemic stroke management. The increasing global incidence of ischemic stroke is fueling demand for neurothrombectomy devices.
Furthermore, continued investments in research and development by industry players stimulate the exploration of cutting-edge technologies and surgical techniques, thereby enhancing the efficacy and safety of neurothrombectomy procedures. These resulting innovations not only contribute to improved patient outcomes but also position the neurothrombectomy market for sustained growth in the dynamic landscape of neurological interventions.
Why are neurorobotics devices gaining traction?
The neurorobotics segment of neurorehabilitation devices industry garnered USD 604 million in 2023 and will grow significantly through 2032, as these devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.
What is the size of neurorehabilitation devices market?
The market size of neurorehabilitation devices was worth USD 1.9 billion in 2023 and is estimated to reach USD 5.8 billion by 2032, as they are designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries.
How big is the U.S. neurorehabilitation devices industry?
The U.S. neurorehabilitation devices market accounted for USD 693 million in 2023 and is predicted to witness substantial growth through 2032, attributed to the country's advanced healthcare infrastructure, a robust R&D landscape, and a high prevalence of neurological disorders.
Who are the makers of neurorehabilitation devices across the globe?
Bioventus LLC, Ectron Ltd., Hocoma (DIH Medical), BIOMETRICS LTD., Bionik Laboratories Corp., BioXtreme Ltd., Ekso bionics holdings, Inc., Kinestica, Saebo, Inc., Abbott Laboratories, Emotiv Inc., BrainCo, Inc, Permobil AB, and Medtronic Plc.